Neurotoxicologists investigate how chemical exposures affect the structure and function of the nervous system. They study the toxic effects of environmental pollutants, pharmaceuticals, industrial chemicals, and natural toxins on brain development, behavior, and neural health. Their work is essential in identifying neurotoxins that cause disorders such as cognitive impairment, peripheral neuropathy, or neurodevelopmental delays. By using cellular models, animal studies, and human biomonitoring, they elucidate mechanisms of neurotoxicity, such as oxidative stress, neurotransmitter disruption, and neuronal death.
Neurotoxicologists collaborate with public health officials, regulatory agencies, and neurologists to assess exposure risks and set safety guidelines for neurotoxic substances. They also examine how genetic variations influence individual susceptibility to neurotoxins, contributing to the field of environmental neurogenetics. Their findings help inform the regulation of consumer products, industrial chemicals, and medications, ensuring neurological safety across populations. With increasing concerns about air pollution, pesticide exposure, and emerging industrial compounds, neurotoxicologists play a crucial role in protecting brain health. Their research underpins public health interventions and the development of therapeutic strategies to mitigate damage caused by neurotoxic agents.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States